Answers are grounded in this paper and cite their sources.
Observational analysis supports MemoPart as a safe option for patent foramen ovale closure, indicating potential clinical benefits.
MemoPart is a safe and effective option for PFO closure, in routine as well as anatomically complex cases. These findings support its routine use and encourage further long-term studies to confirm its clinical benefits.
No takes yet. Share an insight, caveat, or question.
Lanzone et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: